Healthcare Sector Stocks
The Healthcare sector has a total of 1050 stocks, with a combined market cap of $9.94 trillion, total revenue of $4.73 trillion and a weighted average PE ratio of 46.76.
Market Cap
9.94T
Revenue
4.73T
Profits
212.51B
PE Ratio
46.76
Profit Margin
4.49%
Dividend Yield
0.38%
1050 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.24T | -2.06% | 2,747,797 | 86.46B |
| 2 | JNJ | Johnson & Johnson | 660.61B | -0.69% | 4,833,833 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 517.70B | -0.66% | 3,919,689 | 66.01B |
| 4 | MRK | Merck & Co., Inc. | 367.47B | -0.86% | 5,237,906 | 67.38B |
| 5 | UNH | UnitedHealth Group Incorporated | 356.03B | -2.94% | 3,876,528 | 450.06B |
| 6 | NVS | Novartis AG | 307.11B | -1.02% | 1,391,386 | 57.36B |
| 7 | AZN | AstraZeneca PLC | 292.26B | -0.21% | 3,096,612 | 62.38B |
| 8 | AMGN | Amgen Inc. | 253.44B | -2.03% | 2,084,668 | 38.90B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 252.51B | -3.49% | 1,097,384 | 47.35B |
| 10 | GILD | Gilead Sciences, Inc. | 211.50B | -2.27% | 5,135,975 | 30.99B |
| 11 | ABT | Abbott Laboratories | 195.59B | -2.15% | 5,339,782 | 48.23B |
| 12 | NVO | Novo Nordisk A/S | 180.37B | -4.48% | 11,899,827 | 50.70B |
| 13 | PFE | Pfizer Inc. | 173.33B | -1.23% | 25,353,197 | 63.63B |
| 14 | ISRG | Intuitive Surgical, Inc. | 160.08B | -4.21% | 2,540,647 | 11.58B |
| 15 | DHR | Danaher Corporation | 159.81B | -3.31% | 2,089,614 | 25.61B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 138.81B | -0.28% | 1,317,864 | 12.95B |
| 17 | BMY | Bristol-Myers Squibb Company | 129.84B | -1.04% | 4,369,877 | 50.03B |
| 18 | MCK | McKesson Corporation | 126.79B | 1.69% | 752,036 | 418.79B |
| 19 | MDT | Medtronic plc | 126.73B | -1.36% | 6,505,997 | 37.54B |
| 20 | SYK | Stryker Corporation | 125.96B | -2.58% | 2,697,128 | 26.30B |
| 21 | SNY | Sanofi | 111.88B | -1.05% | 5,746,039 | 57.89B |
| 22 | HCA | HCA Healthcare, Inc. | 105.05B | -1.53% | 873,617 | 78.70B |
| 23 | CVS | CVS Health Corporation | 102.37B | 0.10% | 10,948,492 | 418.38B |
| 24 | GSK | GSK plc | 100.95B | -1.15% | 1,703,731 | 44.53B |
| 25 | MRNA | Moderna, Inc. | 95.62B | -7.31% | 7,919,712 | 2.23B |
| 26 | ELV | Elevance Health, Inc. | 92.09B | -1.83% | 937,980 | 201.83B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 91.74B | -1.77% | 796,384 | 16.90B |
| 28 | CI | The Cigna Group | 79.68B | -1.26% | 1,486,224 | 286.32B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 70.70B | 1.47% | 2,271,151 | 29.86B |
| 30 | COR | Cencora, Inc. | 64.92B | -3.90% | 1,076,520 | 337.40B |
| 31 | BSX | Boston Scientific Corporation | 63.94B | -3.73% | 11,703,329 | 21.07B |
| 32 | CAH | Cardinal Health, Inc. | 62.66B | 3.31% | 1,442,945 | 257.75B |
| 33 | BDX | Becton, Dickinson and Company | 57.43B | 0.79% | 2,142,489 | 22.48B |
| 34 | EW | Edwards Lifesciences Corporation | 57.19B | 0.09% | 5,280,151 | 6.67B |
| 35 | ARGX | argenx SE | 55.46B | -3.04% | 248,667 | 5.92B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 52.75B | -4.15% | 439,978 | 4.66B |
| 37 | MDLN | Medline Inc. | 51.68B | -2.53% | 6,649,993 | 30.68B |
| 38 | NTRA | Natera, Inc. | 51.32B | -8.96% | 1,459,954 | 2.71B |
| 39 | VEEV | Veeva Systems Inc. | 50.12B | -0.35% | 1,085,667 | 3.46B |
| 40 | HUM | Humana Inc. | 48.95B | -2.34% | 690,800 | 145.68B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 48.82B | -0.02% | 9,137,424 | 17.23B |
| 42 | A | Agilent Technologies, Inc. | 48.43B | -3.05% | 1,343,373 | 7.37B |
| 43 | WAT | Waters Corporation | 44.47B | -3.20% | 560,417 | 5.61B |
| 44 | ONC | BeOne Medicines AG | 44.09B | 2.64% | 633,459 | 6.61B |
| 45 | IQV | IQVIA Holdings Inc. | 43.15B | -0.74% | 695,988 | 17.31B |
| 46 | HLN | Haleon plc | 39.78B | -0.65% | 25,138,832 | 14.80B |
| 47 | RVMD | Revolution Medicines, Inc. | 39.62B | -7.43% | 4,224,708 | 197.56M |
| 48 | RPRX | Royalty Pharma plc | 39.03B | 0.71% | 2,699,415 | 2.62B |
| 49 | GEHC | GE HealthCare Technologies Inc. | 37.56B | -3.19% | 3,181,082 | 21.64B |
| 50 | ALC | Alcon Inc. | 36.99B | -1.19% | 1,556,797 | 10.86B |
| 51 | BIIB | Biogen Inc. | 36.59B | -2.72% | 369,372 | 10.30B |
| 52 | CNC | Centene Corporation | 36.31B | -3.50% | 4,011,001 | 180.41B |
| 53 | ZTS | Zoetis Inc. | 34.22B | -7.15% | 6,292,513 | 9.52B |
| 54 | MTD | Mettler-Toledo International Inc. | 33.56B | -2.79% | 155,756 | 4.13B |
| 55 | RMD | ResMed Inc. | 32.90B | -2.74% | 707,235 | 5.73B |
| 56 | GMAB | Genmab A/S | 31.22B | -2.76% | 2,595,832 | 4.13B |
| 57 | DXCM | DexCom, Inc. | 31.14B | -5.63% | 2,026,303 | 5.10B |
| 58 | ILMN | Illumina, Inc. | 31.02B | -9.44% | 2,896,858 | 4.54B |
| 59 | PHG | Koninklijke Philips N.V. | 29.78B | -1.32% | 1,186,126 | 20.16B |
| 60 | LH | Labcorp Holdings Inc. | 29.26B | -2.01% | 314,434 | 14.59B |
| 61 | DGX | Quest Diagnostics Incorporated | 27.68B | -1.59% | 329,591 | 11.84B |
| 62 | WST | West Pharmaceutical Services, Inc. | 27.54B | -3.28% | 370,608 | 3.40B |
| 63 | ROIV | Roivant Sciences Ltd. | 26.41B | -4.37% | 5,078,125 | 7.53M |
| 64 | UTHR | United Therapeutics Corporation | 24.58B | -5.81% | 279,505 | 3.19B |
| 65 | STE | STERIS plc | 24.37B | 0.83% | 823,056 | 6.17B |
| 66 | INCY | Incyte Corporation | 24.22B | -3.26% | 561,080 | 6.01B |
| 67 | INSM | Insmed Incorporated | 23.39B | -3.06% | 1,065,072 | 1.52B |
| 68 | THC | Tenet Healthcare Corporation | 22.41B | -3.63% | 585,078 | 22.15B |
| 69 | VTRS | Viatris Inc. | 21.85B | -1.01% | 6,252,414 | 14.73B |
| 70 | BNTX | BioNTech SE | 21.42B | -4.73% | 535,540 | 2.75B |
| 71 | ALNY | Alnylam Pharmaceuticals, Inc. | 21.36B | -0.97% | 1,669,568 | 5.01B |
| 72 | GH | Guardant Health, Inc. | 20.63B | -8.81% | 2,296,654 | 1.18B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 20.24B | -3.66% | 1,763,637 | 8.57B |
| 74 | MEDP | Medpace Holdings, Inc. | 17.90B | -2.54% | 144,724 | 2.84B |
| 75 | RVTY | Revvity, Inc. | 16.98B | -4.58% | 884,731 | 2.94B |
| 76 | EXEL | Exelixis, Inc. | 16.90B | -4.80% | 1,526,874 | 2.50B |
| 77 | ASND | Ascendis Pharma A/S | 16.63B | -1.81% | 171,023 | 1.20B |
| 78 | NBIX | Neurocrine Biosciences, Inc. | 16.46B | -2.06% | 611,967 | 3.70B |
| 79 | CRL | Charles River Laboratories International, Inc. | 15.11B | -3.25% | 917,255 | 3.98B |
| 80 | ICLR | ICON Public Limited Company | 14.83B | -2.56% | 591,259 | 8.23B |
| 81 | JAZZ | Jazz Pharmaceuticals plc | 14.73B | -2.23% | 347,356 | 4.72B |
| 82 | SOLV | Solventum Corporation | 14.69B | -3.41% | 654,648 | 8.31B |
| 83 | BBIO | BridgeBio Pharma, Inc. | 14.56B | -4.06% | 2,082,140 | 945.54M |
| 84 | HALO | Halozyme Therapeutics, Inc. | 14.17B | -4.18% | 977,577 | 1.66B |
| 85 | BTSG | BrightSpring Health Services, Inc. | 13.96B | -4.03% | 1,808,529 | 15.25B |
| 86 | EHC | Encompass Health Corporation | 13.83B | -0.06% | 809,231 | 6.34B |
| 87 | SNN | Smith & Nephew plc | 13.07B | -2.00% | 1,807,589 | 6.30B |
| 88 | GKOS | Glaukos Corporation | 13.07B | -10.49% | 1,180,275 | 690.33M |
| 89 | BAX | Baxter International Inc. | 13.05B | -4.83% | 5,373,006 | 11.61B |
| 90 | PEN | Penumbra, Inc. | 12.63B | -0.61% | 184,831 | 1.56B |
| 91 | TEM | Tempus AI, Inc. | 12.31B | -10.73% | 5,591,628 | 1.51B |
| 92 | DVA | DaVita Inc. | 12.13B | 0.10% | 220,302 | 14.17B |
| 93 | FMS | Fresenius Medical Care AG | 12.09B | 1.42% | 920,601 | 22.12B |
| 94 | COO | The Cooper Companies, Inc. | 11.91B | -2.76% | 760,805 | 4.24B |
| 95 | RDY | Dr. Reddy's Laboratories Limited | 11.85B | -1.22% | 2,095,193 | 3.44B |
| 96 | ELAN | Elanco Animal Health Incorporated | 11.80B | -6.66% | 2,979,632 | 5.02B |
| 97 | UHS | Universal Health Services, Inc. | 11.49B | -0.80% | 622,783 | 18.35B |
| 98 | SMMT | Summit Therapeutics Inc. | 11.44B | -11.50% | 3,363,247 | - |
| 99 | MOH | Molina Healthcare, Inc. | 11.43B | -3.07% | 481,323 | 42.08B |
| 100 | TECH | Bio-Techne Corporation | 11.40B | -0.08% | 2,960,174 | 1.22B |
| 101 | ALGN | Align Technology, Inc. | 11.23B | -4.17% | 702,099 | 4.16B |
| 102 | BMRN | BioMarin Pharmaceutical Inc. | 11.00B | -0.54% | 811,090 | 3.66B |
| 103 | GMED | Globus Medical, Inc. | 10.82B | -7.45% | 1,792,529 | 3.14B |
| 104 | RGEN | Repligen Corporation | 10.76B | -5.58% | 637,224 | 805.61M |
| 105 | KYMR | Kymera Therapeutics, Inc. | 10.75B | -7.56% | 754,824 | 102.24M |
| 106 | ENSG | The Ensign Group, Inc. | 10.61B | -2.56% | 162,628 | 5.67B |
| 107 | PODD | Insulet Corporation | 10.61B | -7.33% | 664,429 | 3.19B |
| 108 | OSCR | Oscar Health, Inc. | 10.58B | -2.47% | 7,642,896 | 17.47B |
| 109 | QGEN | Qiagen N.V. | 10.49B | -0.20% | 2,638,049 | 2.12B |
| 110 | AVTR | Avantor, Inc. | 10.34B | -2.49% | 3,700,350 | 6.64B |
| 111 | BIO | Bio-Rad Laboratories, Inc. | 9.99B | -2.24% | 226,812 | 2.59B |
| 112 | PCVX | Vaxcyte, Inc. | 9.84B | -4.83% | 635,324 | - |
| 113 | HNGE | Hinge Health, Inc. | 9.45B | -3.15% | 756,456 | 800.82M |
| 114 | HSIC | Henry Schein, Inc. | 9.39B | -3.77% | 799,508 | 13.73B |
| 115 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.32B | 0.17% | 462,231 | 1.43B |
| 116 | SYRE | Spyre Therapeutics, Inc. | 9.09B | -3.36% | 463,507 | - |
| 117 | ATR | AptarGroup, Inc. | 9.09B | -2.41% | 290,893 | 3.99B |
| 118 | KRYS | Krystal Biotech, Inc. | 8.93B | -3.10% | 122,084 | 470.03M |
| 119 | BRKR | Bruker Corporation | 8.86B | -8.83% | 1,956,784 | 3.51B |
| 120 | PTGX | Protagonist Therapeutics, Inc. | 8.78B | -5.35% | 224,703 | 281.99M |
| 121 | HQY | HealthEquity, Inc. | 8.56B | -4.93% | 824,269 | 1.36B |
| 122 | IBRX | ImmunityBio, Inc. | 8.53B | -9.85% | 8,105,426 | 165.79M |
| 123 | TGTX | TG Therapeutics, Inc. | 8.37B | -4.23% | 1,011,099 | 799.54M |
| 124 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.18B | -6.05% | 997,323 | 669.50M |
| 125 | CORT | Corcept Therapeutics Incorporated | 7.99B | -7.79% | 668,607 | 963.65M |
| 126 | PACS | PACS Group, Inc. | 7.99B | 0.14% | 704,739 | 5.71B |
| 127 | CYTK | Cytokinetics, Incorporated | 7.65B | -13.44% | 4,066,998 | 113.29M |
| 128 | TWST | Twist Bioscience Corporation | 7.61B | -14.87% | 1,771,518 | 431.80M |
| 129 | TXG | 10x Genomics, Inc. | 7.60B | -13.60% | 3,235,180 | 616.91M |
| 130 | ALKS | Alkermes plc | 7.52B | -2.31% | 837,645 | 1.75B |
| 131 | PRAX | Praxis Precision Medicines, Inc. | 7.39B | -7.03% | 143,983 | 7.46M |
| 132 | ABVX | ABIVAX Société Anonyme | 7.36B | -5.45% | 805,995 | 5.33M |
| 133 | GRFS | Grifols, S.A. | 7.35B | -1.97% | 426,955 | 8.63B |
| 134 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.24B | -5.71% | 3,717,474 | 280.75M |
| 135 | CAI | Caris Life Sciences, Inc. | 7.22B | -23.06% | 5,164,642 | 1.05B |
| 136 | BLCO | Bausch + Lomb Corporation | 7.16B | -2.84% | 405,215 | 5.42B |
| 137 | KNSA | Kiniksa Pharmaceuticals International, plc | 7.06B | -6.51% | 420,404 | 945.96M |
| 138 | CHE | Chemed Corporation | 6.88B | -3.24% | 50,817 | 2.66B |
| 139 | AXSM | Axsome Therapeutics, Inc. | 6.86B | -4.74% | 586,006 | 865.27M |
| 140 | AMRX | Amneal Pharmaceuticals, Inc. | 6.81B | -2.01% | 861,100 | 3.20B |
| 141 | LNTH | Lantheus Holdings, Inc. | 6.59B | -0.14% | 503,439 | 1.56B |
| 142 | TFX | Teleflex Incorporated | 6.44B | 1.36% | 591,819 | 2.26B |
| 143 | IONS | Ionis Pharmaceuticals, Inc. | 6.40B | -4.03% | 1,035,707 | 874.09M |
| 144 | ORKA | Oruka Therapeutics, Inc. | 6.34B | -5.63% | 358,286 | - |
| 145 | MIRM | Mirum Pharmaceuticals, Inc. | 6.20B | -2.11% | 450,036 | 670.78M |
| 146 | RDNT | RadNet, Inc. | 6.14B | -2.87% | 498,771 | 2.27B |
| 147 | LGND | Ligand Pharmaceuticals Incorporated | 6.00B | -5.06% | 108,288 | 253.83M |
| 148 | DOCS | Doximity, Inc. | 5.99B | -3.13% | 1,177,164 | 655.57M |
| 149 | IMVT | Immunovant, Inc. | 5.89B | -4.68% | 407,062 | - |
| 150 | KOD | Kodiak Sciences Inc. | 5.79B | -6.28% | 551,218 | - |
| 151 | CGON | CG Oncology, Inc. | 5.78B | -3.62% | 406,752 | 6.23M |
| 152 | BLTE | Belite Bio, Inc | 5.78B | -6.82% | 158,266 | - |
| 153 | HAE | Haemonetics Corporation | 5.58B | -3.76% | 532,570 | 1.38B |
| 154 | SUPN | Supernus Pharmaceuticals, Inc. | 5.58B | -4.82% | 2,755,362 | 1.37B |
| 155 | PTCT | PTC Therapeutics, Inc. | 5.54B | -3.91% | 464,283 | 1.16B |
| 156 | SRRK | Scholar Rock Holding Corporation | 5.53B | -1.45% | 771,195 | - |
| 157 | WAY | Waystar Holding Corp. | 5.50B | -3.67% | 866,249 | 1.26B |
| 158 | LFST | LifeStance Health Group, Inc. | 5.48B | 0.84% | 4,827,951 | 1.68B |
| 159 | HIMS | Hims & Hers Health, Inc. | 5.45B | -12.38% | 11,820,323 | 2.58B |
| 160 | CON | Concentra Group Holdings Parent, Inc. | 5.42B | -2.39% | 884,821 | 2.29B |
| 161 | GRAL | GRAIL, Inc. | 5.36B | -16.47% | 1,414,306 | 166.60M |
| 162 | MMSI | Merit Medical Systems, Inc. | 5.35B | -1.43% | 531,031 | 1.61B |
| 163 | MANE | Veradermics, Incorporated | 5.27B | -7.60% | 408,405 | - |
| 164 | COGT | Cogent Biosciences, Inc. | 5.13B | -6.11% | 1,485,715 | - |
| 165 | BLLN | BillionToOne, Inc. | 5.12B | -4.79% | 1,214,932 | 436.87M |
| 166 | MMED | MiniMed Group, Inc. | 5.03B | -7.39% | 5,046,187 | 3.22B |
| 167 | LIVN | LivaNova PLC | 4.93B | -4.96% | 540,930 | 1.51B |
| 168 | ERAS | Erasca, Inc. | 4.74B | -9.12% | 3,663,700 | - |
| 169 | OPCH | Option Care Health, Inc. | 4.74B | -0.09% | 2,361,342 | 5.75B |
| 170 | CRSP | CRISPR Therapeutics AG | 4.70B | -6.48% | 1,147,216 | 25.17M |
| 171 | TVTX | Travere Therapeutics, Inc. | 4.69B | -6.77% | 797,342 | 651.03M |
| 172 | DNTH | Dianthus Therapeutics, Inc. | 4.61B | -4.00% | 495,944 | 2.72M |
| 173 | HTFL | HeartFlow, Inc. | 4.59B | -6.75% | 719,763 | 212.07M |
| 174 | SHC | Sotera Health Company | 4.58B | -2.20% | 877,069 | 1.23B |
| 175 | LEGN | Legend Biotech Corporation | 4.43B | 0.31% | 1,688,784 | 1.27B |
| 176 | EWTX | Edgewise Therapeutics, Inc. | 4.36B | 7.06% | 3,211,492 | - |
| 177 | ITGR | Integer Holdings Corporation | 4.31B | - | 719,258 | 1.83B |
| 178 | IRTC | iRhythm Holdings, Inc. | 4.26B | -3.57% | 315,155 | 825.34M |
| 179 | DFTX | Definium Therapeutics, Inc. | 4.16B | -5.35% | 979,657 | - |
| 180 | ICUI | ICU Medical, Inc. | 4.15B | -3.90% | 202,134 | 2.16B |
| 181 | ADPT | Adaptive Biotechnologies Corporation | 4.14B | -2.85% | 2,559,696 | 298.01M |
| 182 | LQDA | Liquidia Corporation | 4.07B | -4.09% | 993,383 | 450.91M |
| 183 | CDNA | CareDx, Inc. | 4.02B | -10.84% | 1,285,587 | 497.40M |
| 184 | NVST | Envista Holdings Corporation | 3.97B | -9.01% | 3,259,086 | 2.88B |
| 185 | ACAD | Acadia Pharmaceuticals Inc. | 3.76B | 1.54% | 4,075,052 | 1.20B |
| 186 | RLAY | Relay Therapeutics, Inc. | 3.71B | -6.05% | 1,658,999 | 10.35M |
| 187 | XENE | Xenon Pharmaceuticals Inc. | 3.67B | -3.39% | 529,836 | 7.50M |
| 188 | STVN | Stevanato Group S.p.A. | 3.66B | -0.30% | 3,139,321 | 1.42B |
| 189 | PLSE | Pulse Biosciences, Inc. | 3.66B | -10.15% | 289,234 | 1.19M |
| 190 | OGN | Organon & Co. | 3.63B | -0.07% | 2,241,503 | 6.10B |
| 191 | TNGX | Tango Therapeutics, Inc. | 3.62B | -7.29% | 1,508,698 | 53.81M |
| 192 | ABCL | AbCellera Biologics Inc. | 3.60B | -9.53% | 2,681,627 | 66.17M |
| 193 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.55B | -3.91% | 849,226 | -665.00K |
| 194 | IRON | Disc Medicine, Inc. | 3.54B | -4.33% | 323,566 | - |
| 195 | IOVA | Iovance Biotherapeutics, Inc. | 3.52B | -10.75% | 15,653,668 | 378.98M |
| 196 | PBLS | Parabilis Medicines, Inc. | 3.45B | -8.10% | 354,393 | 148.00K |
| 197 | TARS | Tarsus Pharmaceuticals, Inc. | 3.35B | -1.52% | 465,933 | 682.20M |
| 198 | DYN | Dyne Therapeutics, Inc. | 3.34B | -3.67% | 1,369,833 | - |
| 199 | ARQT | Arcutis Biotherapeutics, Inc. | 3.33B | -22.61% | 4,051,990 | 508.68M |
| 200 | WRBY | Warby Parker Inc. | 3.32B | 26.26% | 6,533,019 | 934.66M |
| 201 | ELVN | Enliven Therapeutics, Inc. | 3.30B | -4.72% | 738,941 | - |
| 202 | VKTX | Viking Therapeutics, Inc. | 3.28B | -8.15% | 2,809,068 | - |
| 203 | VRDN | Viridian Therapeutics, Inc. | 3.27B | -0.64% | 2,169,764 | 26.31M |
| 204 | TLX | Telix Pharmaceuticals Limited | 3.26B | -2.69% | 155,613 | 890.79M |
| 205 | ACHC | Acadia Healthcare Company, Inc. | 3.25B | 8.40% | 2,956,005 | 3.41B |
| 206 | NHC | National HealthCare Corporation | 3.24B | -2.50% | 64,869 | 1.56B |
| 207 | DNLI | Denali Therapeutics Inc. | 3.20B | -4.63% | 1,087,030 | 21.38M |
| 208 | CELC | Celcuity Inc. | 3.13B | -7.57% | 626,766 | - |
| 209 | ATRC | AtriCure, Inc. | 3.13B | -6.10% | 501,008 | 589.80M |
| 210 | ADMA | ADMA Biologics, Inc. | 3.04B | 29.68% | 10,770,973 | 519.15M |
| 211 | BHC | Bausch Health Companies Inc. | 3.01B | -3.66% | 1,754,692 | 11.11B |
| 212 | SGRY | Surgery Partners, Inc. | 3.00B | 0.02% | 3,312,785 | 3.37B |
| 213 | IDYA | IDEAYA Biosciences, Inc. | 2.99B | -4.39% | 531,640 | 36.54M |
| 214 | AVAH | Aveanna Healthcare Holdings Inc. | 2.96B | -4.78% | 1,220,404 | 2.60B |
| 215 | PRVA | Privia Health Group, Inc. | 2.95B | 3.17% | 1,275,327 | 2.43B |
| 216 | AXGN | Axogen, Inc. | 2.86B | -6.76% | 545,522 | 266.93M |
| 217 | ZLAB | Zai Lab Limited | 2.79B | -1.29% | 348,604 | 441.73M |
| 218 | RCUS | Arcus Biosciences, Inc. | 2.62B | -5.54% | 959,998 | 100.00M |
| 219 | PGNY | Progyny, Inc. | 2.61B | 13.22% | 1,527,893 | 1.34B |
| 220 | VCEL | Vericel Corporation | 2.58B | 10.66% | 1,452,999 | 324.17M |
| 221 | XNCR | Xencor, Inc. | 2.57B | -1.14% | 670,731 | 200.49M |
| 222 | RGC | Regencell Bioscience Holdings Limited | 2.57B | -4.34% | 154,075 | - |
| 223 | BEAM | Beam Therapeutics Inc. | 2.54B | -8.13% | 1,988,771 | 146.64M |
| 224 | BKD | Brookdale Senior Living Inc. | 2.53B | -5.45% | 3,082,788 | 2.93B |
| 225 | NEOG | Neogen Corporation | 2.52B | -7.22% | 2,103,472 | 884.00M |
| 226 | GRDN | Guardian Pharmacy Services, Inc. | 2.51B | -5.84% | 366,616 | 1.46B |
| 227 | HCM | HUTCHMED (China) Limited | 2.45B | 1.46% | 50,391 | 549.12M |
| 228 | MD | Pediatrix Medical Group, Inc. | 2.43B | -2.87% | 507,751 | 1.96B |
| 229 | XERS | Xeris Biopharma Holdings, Inc. | 2.38B | 24.76% | 8,150,952 | 368.26M |
| 230 | TMDX | TransMedics Group, Inc. | 2.35B | -7.03% | 625,816 | 668.47M |
| 231 | CLOV | Clover Health Investments, Corp. | 2.34B | -5.97% | 5,961,305 | 2.74B |
| 232 | NAMS | NewAmsterdam Pharma Company N.V. | 2.33B | -6.74% | 715,834 | 25.94M |
| 233 | MBX | MBX Biosciences, Inc. | 2.32B | -8.16% | 196,168 | - |
| 234 | PHVS | Pharvaris N.V. | 2.32B | -3.73% | 563,901 | - |
| 235 | ADUS | Addus HomeCare Corporation | 2.31B | -1.20% | 129,315 | 1.50B |
| 236 | UFPT | UFP Technologies, Inc. | 2.26B | -11.59% | 97,305 | 649.52M |
| 237 | CLDX | Celldex Therapeutics, Inc. | 2.25B | -4.48% | 413,419 | 158.00K |
| 238 | PVLA | Palvella Therapeutics, Inc. | 2.23B | -4.45% | 172,148 | - |
| 239 | VERA | Vera Therapeutics, Inc. | 2.21B | -3.94% | 744,514 | - |
| 240 | AUPH | Aurinia Pharmaceuticals Inc. | 2.20B | -4.15% | 465,584 | 321.74M |
| 241 | PRGO | Perrigo Company plc | 2.17B | -1.07% | 1,209,793 | 4.09B |
| 242 | SEPN | Septerna, Inc. | 2.17B | -2.88% | 178,887 | 98.88M |
| 243 | RXRX | Recursion Pharmaceuticals, Inc. | 2.16B | -10.82% | 16,984,722 | 68.23M |
| 244 | TRLV | Trulieve Cannabis Corp. | 2.15B | -3.58% | 974,276 | 1.14B |
| 245 | ARDT | Ardent Health, Inc. | 2.14B | 17.01% | 1,320,261 | 6.45B |
| 246 | BHVN | Biohaven Ltd. | 2.14B | -7.22% | 1,727,046 | - |
| 247 | SDGR | Schrödinger, Inc. | 2.14B | 0.09% | 1,427,542 | 269.20M |
| 248 | LKFT | Lakefront Biotherapeutics NV | 2.12B | -0.78% | 182,580 | 1.13B |
| 249 | IMNM | Immunome, Inc. | 2.12B | -7.97% | 1,311,631 | 4.02M |
| 250 | PBH | Prestige Consumer Healthcare Inc. | 2.11B | -16.42% | 783,850 | 1.17B |
| 251 | COAG | Hemab Therapeutics Holdings, Inc. | 2.10B | -0.47% | 201,239 | - |
| 252 | NEO | NeoGenomics, Inc. | 2.10B | -5.54% | 1,327,491 | 787.75M |
| 253 | ZYME | Zymeworks Inc. | 2.07B | -5.51% | 698,472 | 37.13M |
| 254 | XRAY | DENTSPLY SIRONA Inc. | 2.01B | -5.35% | 2,263,449 | 3.64B |
| 255 | ASTH | Astrana Health, Inc. | 1.99B | -1.81% | 199,506 | 3.84B |
| 256 | FTRE | Fortrea Holdings Inc. | 1.95B | -2.86% | 1,335,719 | 2.67B |
| 257 | MESO | Mesoblast Limited | 1.94B | -1.47% | 143,350 | 120.25M |
| 258 | TRAX | First Tracks Biotherapeutics, Inc. | 1.94B | -5.83% | 306,804 | - |
| 259 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.93B | -8.50% | 4,286,014 | 961.51M |
| 260 | REPL | Replimune Group, Inc. | 1.93B | -1.69% | 2,058,444 | - |
| 261 | HRMY | Harmony Biosciences Holdings, Inc. | 1.91B | -4.66% | 643,979 | 989.36M |
| 262 | SRPT | Sarepta Therapeutics, Inc. | 1.89B | -5.63% | 663,193 | 1.97B |
| 263 | TRVI | Trevi Therapeutics, Inc. | 1.89B | -5.15% | 400,912 | - |
| 264 | INSP | Inspire Medical Systems, Inc. | 1.89B | -2.18% | 426,996 | 880.94M |
| 265 | ESTA | Establishment Labs Holdings Inc. | 1.87B | -6.24% | 269,860 | 264.03M |
| 266 | VIR | Vir Biotechnology, Inc. | 1.87B | -6.12% | 1,672,761 | 302.80M |
| 267 | LMAT | LeMaitre Vascular, Inc. | 1.86B | -7.43% | 341,309 | 269.36M |
| 268 | WGS | GeneDx Holdings Corp. | 1.86B | -10.20% | 442,860 | 454.43M |
| 269 | ALMR | Alamar Biosciences, Inc. | 1.84B | -3.03% | 650,937 | 114.05M |
| 270 | AGL | agilon health, inc. | 1.82B | 12.47% | 330,459 | 6.00B |
| 271 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.81B | -9.59% | 1,633,914 | 213.00M |
| 272 | AMN | AMN Healthcare Services, Inc. | 1.79B | -2.95% | 303,472 | 3.43B |
| 273 | VCYT | Veracyte, Inc. | 1.78B | -57.73% | 10,321,360 | 581.78M |
| 274 | ZBIO | Zenas BioPharma, Inc. | 1.75B | -5.67% | 376,429 | 11.00M |
| 275 | CERT | Certara, Inc. | 1.75B | 3.43% | 1,537,145 | 412.03M |
| 276 | MAZE | Maze Therapeutics, Inc. | 1.72B | -4.28% | 242,145 | 20.00M |
| 277 | STOK | Stoke Therapeutics, Inc. | 1.72B | -4.26% | 449,535 | 28.21M |
| 278 | TDOC | Teladoc Health, Inc. | 1.71B | -3.04% | 7,252,227 | 2.47B |
| 279 | HCSG | Healthcare Services Group, Inc. | 1.71B | -4.54% | 441,958 | 1.88B |
| 280 | OMCL | Omnicell, Inc. | 1.70B | -5.18% | 360,946 | 1.24B |
| 281 | AGIO | Agios Pharmaceuticals, Inc. | 1.69B | -9.66% | 1,230,377 | 140.84M |
| 282 | NRIX | Nurix Therapeutics, Inc. | 1.69B | -3.20% | 3,799,825 | 701.94M |
| 283 | PSNL | Personalis, Inc. | 1.67B | -1.14% | 2,406,970 | 80.77M |
| 284 | KMTS | Kestra Medical Technologies, Ltd. | 1.66B | -8.67% | 289,510 | 106.73M |
| 285 | LYCA | Lycia Therapeutics, Inc. | 1.66B | -0.59% | 81,198 | 4.44M |
| 286 | ALVO | Alvotech | 1.63B | -1.93% | 429,652 | 494.61M |
| 287 | AZTA | Azenta, Inc. | 1.63B | -5.08% | 371,367 | 613.81M |
| 288 | ABSI | Absci Corporation | 1.62B | -9.92% | 3,142,685 | 1.56M |
| 289 | SLS | SELLAS Life Sciences Group, Inc. | 1.62B | -12.31% | 7,501,168 | - |
| 290 | GENB | Generate Biomedicines, Inc. | 1.61B | -11.16% | 528,141 | 26.48M |
| 291 | SNDA | Sonida Senior Living, Inc. | 1.61B | -8.07% | 573,325 | 593.38M |
| 292 | ENOV | Enovis Corporation | 1.60B | 13.88% | 3,215,975 | 2.31B |
| 293 | BFLY | Butterfly Network, Inc. | 1.60B | -11.60% | 4,119,146 | 123.26M |
| 294 | NVCR | NovoCure Limited | 1.60B | -6.30% | 722,892 | 725.39M |
| 295 | ALHC | Alignment Healthcare, Inc. | 1.59B | -6.63% | 2,267,023 | 4.94B |
| 296 | KLRA | Kailera Therapeutics, Inc. | 1.59B | -4.18% | 350,313 | - |
| 297 | NVAX | Novavax, Inc. | 1.59B | -9.48% | 5,738,593 | 413.80M |
| 298 | NBTX | Nanobiotix S.A. | 1.57B | 0.94% | 374,943 | 13.15M |
| 299 | RARE | Ultragenyx Pharmaceutical Inc. | 1.56B | -7.28% | 3,101,887 | 730.00M |
| 300 | NTLA | Intellia Therapeutics, Inc. | 1.55B | -10.07% | 4,456,998 | 52.89M |
| 301 | CNMD | CONMED Corporation | 1.55B | -3.32% | 177,962 | 1.37B |
| 302 | NUVB | Nuvation Bio Inc. | 1.54B | -7.40% | 4,863,790 | 201.73M |
| 303 | ANIP | ANI Pharmaceuticals, Inc. | 1.51B | -1.62% | 817,693 | 1.04B |
| 304 | ADRX | ADARx Pharmaceuticals, Inc. | 1.46B | -12.70% | 478,077 | 6.13M |
| 305 | TYRA | Tyra Biosciences, Inc. | 1.46B | -1.16% | 249,374 | - |
| 306 | IMCR | Immunocore Holdings plc | 1.46B | -2.87% | 173,738 | 430.78M |
| 307 | PGEN | Precigen, Inc. | 1.45B | -19.68% | 19,420,617 | 156.94M |
| 308 | USPH | U.S. Physical Therapy, Inc. | 1.45B | 9.17% | 152,201 | 829.86M |
| 309 | PCRX | Pacira BioSciences, Inc. | 1.45B | 0.08% | 729,952 | 746.16M |
| 310 | QURE | uniQure N.V. | 1.45B | -9.47% | 1,630,430 | 20.17M |
| 311 | INVA | Innoviva, Inc. | 1.44B | -6.02% | 735,667 | 438.32M |
| 312 | OCUL | Ocular Therapeutix, Inc. | 1.44B | -8.26% | 1,747,066 | 52.06M |
| 313 | RAPP | Rapport Therapeutics, Inc. | 1.43B | -6.79% | 316,311 | 20.00M |
| 314 | PAHC | Phibro Animal Health Corporation | 1.42B | -11.11% | 133,348 | 1.54B |
| 315 | BRVE | Braveheart Bio, Inc. | 1.42B | -13.50% | 829,213 | - |
| 316 | AAPG | Ascentage Pharma Group International | 1.41B | -0.80% | 3,893 | 94.61M |
| 317 | ANAB | AnaptysBio, Inc. | 1.40B | -1.16% | 193,539 | 106.09M |
| 318 | CRON | Cronos Group Inc. | 1.39B | 7.12% | 2,963,743 | 179.09M |
| 319 | MLYS | Mineralys Therapeutics, Inc. | 1.39B | -7.35% | 1,039,709 | - |
| 320 | ETON | Eton Pharmaceuticals, Inc. | 1.39B | -4.28% | 279,973 | 105.60M |
| 321 | TSHA | Taysha Gene Therapies, Inc. | 1.38B | -2.75% | 2,760,278 | 5.49M |
| 322 | KRSA | Korsana Biosciences, Inc. | 1.37B | -1.42% | 62,545 | - |
| 323 | GPCR | Structure Therapeutics Inc. | 1.34B | -7.56% | 466,034 | - |
| 324 | STAA | STAAR Surgical Company | 1.32B | -2.76% | 757,357 | 328.27M |
| 325 | KARD | Kardigan, Inc. | 1.32B | -9.58% | 268,127 | - |
| 326 | DMRA | Damora Therapeutics, Inc. | 1.31B | -7.19% | 371,372 | - |
| 327 | LMRI | Lumexa Imaging Holdings, Inc. | 1.30B | 3.44% | 221,842 | 1.04B |
| 328 | NUTX | Nutex Health Inc. | 1.30B | -7.42% | 87,696 | 846.72M |
| 329 | GHRS | GH Research PLC | 1.29B | -5.47% | 221,062 | - |
| 330 | URGN | UroGen Pharma Ltd. | 1.28B | -8.91% | 1,430,126 | 250.25M |
| 331 | PNTG | The Pennant Group, Inc. | 1.27B | -17.25% | 754,874 | 1.17B |
| 332 | OPK | OPKO Health, Inc. | 1.25B | -5.08% | 5,105,462 | 654.10M |
| 333 | LBRX | LB Pharmaceuticals Inc | 1.25B | -5.17% | 191,759 | - |
| 334 | OMER | Omeros Corporation | 1.24B | -5.89% | 560,874 | 38.42M |
| 335 | INNV | InnovAge Holding Corp. | 1.23B | -7.66% | 237,940 | 1.02B |
| 336 | TNDM | Tandem Diabetes Care, Inc. | 1.23B | -7.09% | 984,539 | 1.04B |
| 337 | NKTR | Nektar Therapeutics | 1.23B | -6.44% | 290,182 | 54.59M |
| 338 | DRTS | Alpha Tau Medical Ltd. | 1.23B | -5.42% | 451,402 | - |
| 339 | AORT | Artivion, Inc. | 1.21B | -6.20% | 407,119 | 471.47M |
| 340 | ATEC | Alphatec Holdings, Inc. | 1.20B | -6.52% | 1,788,299 | 839.72M |
| 341 | GDRX | GoodRx Holdings, Inc. | 1.20B | -5.65% | 731,906 | 785.23M |
| 342 | SLN | Silence Therapeutics plc | 1.19B | -0.08% | 598,445 | 615.00K |
| 343 | INBX | Inhibrx Biosciences, Inc. | 1.18B | -7.22% | 118,852 | 1.30M |
| 344 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.18B | -0.71% | 285,256 | 730.02M |
| 345 | MNKD | MannKind Corporation | 1.18B | -6.49% | 2,609,637 | 393.63M |
| 346 | PRCT | PROCEPT BioRobotics Corporation | 1.18B | -5.45% | 1,740,636 | 352.31M |
| 347 | AVLN | Avalyn Pharma Inc. | 1.17B | -4.00% | 189,418 | - |
| 348 | VOR | Vor Biopharma Inc. | 1.15B | -6.66% | 330,292 | - |
| 349 | VSTM | Verastem, Inc. | 1.15B | -4.06% | 1,502,012 | 87.53M |
| 350 | AHG | Akso Health Group | 1.14B | - | 447 | 13.83M |
| 351 | FRNM | Freenome, Inc. | 1.14B | -6.28% | 816,240 | 35.41M |
| 352 | OMDA | Omada Health, Inc. | 1.13B | -4.68% | 796,593 | 309.76M |
| 353 | SVRA | Savara Inc. | 1.12B | -5.79% | 1,102,529 | - |
| 354 | SGP | SpyGlass Pharma, Inc. | 1.12B | -3.22% | 100,089 | - |
| 355 | CMPS | COMPASS Pathways plc | 1.11B | -6.86% | 2,538,082 | - |
| 356 | SIBN | SI-BONE, Inc. | 1.08B | -4.19% | 275,564 | 220.65M |
| 357 | IRMD | IRADIMED CORPORATION | 1.08B | -4.81% | 51,113 | 89.34M |
| 358 | SPTX | Seaport Therapeutics, Inc. | 1.08B | -4.17% | 82,952 | - |
| 359 | IART | Integra LifeSciences Holdings Corporation | 1.07B | -6.82% | 405,422 | 1.66B |
| 360 | JANX | Janux Therapeutics, Inc. | 1.05B | -5.89% | 363,576 | 24.00M |
| 361 | CSTL | Castle Biosciences, Inc. | 1.04B | -4.67% | 236,096 | 357.28M |
| 362 | CBLL | CeriBell, Inc. | 1.04B | -2.59% | 456,685 | 108.72M |
| 363 | HROW | Harrow, Inc. | 986.68M | -8.45% | 411,032 | 275.59M |
| 364 | AHCO | AdaptHealth Corp. | 984.56M | 0.82% | 2,560,797 | 3.44B |
| 365 | GMRS | GMR Solutions Inc. | 949.76M | -1.37% | 380,307 | 5.88B |
| 366 | MLTX | MoonLake Immunotherapeutics | 931.92M | -5.28% | 720,005 | - |
| 367 | HSTM | HealthStream, Inc. | 922.77M | -7.14% | 157,027 | 327.95M |
| 368 | JBIO | Jade Biosciences, Inc. | 920.25M | -3.79% | 528,365 | - |
| 369 | ORIC | ORIC Pharmaceuticals, Inc. | 915.63M | -5.42% | 627,224 | - |
| 370 | ODTX | Odyssey Therapeutics, Inc. | 909.01M | -2.72% | 262,532 | 99.00K |
| 371 | IVA | Inventiva S.A. | 896.26M | -4.65% | 1,635,610 | 2.81M |
| 372 | RIGL | Rigel Pharmaceuticals, Inc. | 889.54M | -7.16% | 160,606 | 276.79M |
| 373 | GLUE | Monte Rosa Therapeutics, Inc. | 888.97M | -3.70% | 475,904 | 70.33M |
| 374 | BVS | Bioventus Inc. | 878.42M | -8.71% | 326,291 | 585.64M |
| 375 | ANRO | Alto Neuroscience, Inc. | 877.45M | -4.03% | 223,458 | - |
| 376 | LTGO | Latigo Biotherapeutics, Inc. | 873.16M | -6.20% | 310,883 | - |
| 377 | PHAR | Pharming Group N.V. | 868.52M | -1.36% | 11,898 | 386.75M |
| 378 | SNDX | Syndax Pharmaceuticals, Inc. | 857.07M | -8.90% | 3,139,569 | 289.68M |
| 379 | IMTX | Immatics N.V. | 855.68M | -9.41% | 651,628 | 47.65M |
| 380 | KIDS | OrthoPediatrics Corp. | 845.46M | -3.37% | 145,990 | 264.14M |
| 381 | CTY | City Therapeutics, Inc. | 843.63M | 3.32% | 78,755 | 14.34M |
| 382 | QDEL | QuidelOrtho Corporation | 832.96M | -15.40% | 1,870,337 | 2.59B |
| 383 | COLL | Collegium Pharmaceutical, Inc. | 828.54M | 7.52% | 774,008 | 815.19M |
| 384 | MGTX | MeiraGTx Holdings plc | 827.89M | -8.49% | 280,263 | 397.50M |
| 385 | CRVS | Corvus Pharmaceuticals, Inc. | 826.91M | -7.00% | 568,456 | - |
| 386 | BBNX | Beta Bionics, Inc. | 820.40M | -10.97% | 475,719 | 127.27M |
| 387 | AKTS | Aktis Oncology, Inc. | 809.82M | -4.21% | 191,951 | 10.06M |
| 388 | BBTX | Bambusa Therapeutics, Inc. | 791.14M | -3.36% | 314,928 | - |
| 389 | PHR | Phreesia, Inc. | 788.92M | -3.57% | 332,921 | 507.79M |
| 390 | PRME | Prime Medicine, Inc. | 781.00M | -11.67% | 3,041,157 | 4.07M |
| 391 | VREX | Varex Imaging Corporation | 777.42M | -0.35% | 395,086 | 865.00M |
| 392 | INMD | InMode Ltd. | 775.42M | -5.00% | 288,893 | 374.63M |
| 393 | ARDX | Ardelyx, Inc. | 771.71M | -6.69% | 4,136,750 | 468.22M |
| 394 | PACB | Pacific Biosciences of California, Inc. | 761.54M | -3.92% | 14,850,491 | 161.39M |
| 395 | ALMS | Alumis Inc. | 757.84M | -10.61% | 685,293 | 7.40M |
| 396 | ANNX | Annexon, Inc. | 754.52M | -8.08% | 2,147,875 | - |
| 397 | ABUS | Arbutus Biopharma Corporation | 732.04M | -8.87% | 4,288,732 | 181.72M |
| 398 | CGEM | Cullinan Therapeutics, Inc. | 726.89M | -9.57% | 977,102 | - |
| 399 | LXRX | Lexicon Pharmaceuticals, Inc. | 716.38M | 8.78% | 2,894,749 | 38.54M |
| 400 | CTKB | Cytek Biosciences, Inc. | 709.71M | -7.14% | 729,916 | 207.65M |
| 401 | OABI | OmniAb, Inc. | 703.05M | -6.95% | 578,963 | 40.21M |
| 402 | SANA | Sana Biotechnology, Inc. | 696.01M | -9.18% | 1,619,219 | - |
| 403 | ATTO | Attovia Therapeutics, Inc. | 680.66M | -4.42% | 185,354 | 1.80M |
| 404 | STLN | Starling Oncology, Inc. | 678.76M | -4.03% | 874,902 | 587.24M |
| 405 | DNA | Ginkgo Bioworks Holdings, Inc. | 674.08M | -14.08% | 1,183,997 | 132.42M |
| 406 | SLDB | Solid Biosciences Inc. | 661.58M | -5.37% | 819,641 | - |
| 407 | SGMT | Sagimet Biosciences Inc. | 661.58M | -6.61% | 543,137 | - |
| 408 | AURA | Aura Biosciences, Inc. | 660.60M | -4.21% | 345,107 | - |
| 409 | EVO | Evotec SE | 646.23M | 4.78% | 117,294 | 815.72M |
| 410 | ACHV | Achieve Life Sciences, Inc. | 646.23M | -10.03% | 972,969 | - |
| 411 | IRWD | Ironwood Pharmaceuticals, Inc. | 644.44M | 3.45% | 2,780,538 | 400.30M |
| 412 | ZVRA | Zevra Therapeutics, Inc. | 641.46M | -3.49% | 991,500 | 147.76M |
| 413 | WVE | Wave Life Sciences, Inc. | 640.99M | -10.22% | 2,645,032 | 70.92M |
| 414 | OBX | Obsidian Therapeutics, Inc. | 638.42M | -5.96% | 294,831 | - |
| 415 | KURA | Kura Oncology, Inc. | 630.73M | -6.83% | 1,943,850 | 77.23M |
| 416 | HELP | Helus Pharma Inc. | 629.05M | -0.81% | 954,721 | - |
| 417 | FDMT | 4D Molecular Therapeutics, Inc. | 625.36M | -7.82% | 589,249 | 92.01M |
| 418 | DSGN | Design Therapeutics, Inc. | 625.19M | -6.02% | 231,145 | - |
| 419 | CADL | Candel Therapeutics, Inc. | 624.39M | -9.83% | 688,485 | - |
| 420 | GERN | Geron Corporation | 607.97M | -12.38% | 17,117,818 | 217.52M |
| 421 | DBVT | DBV Technologies S.A. | 607.60M | -2.31% | 186,155 | 3.74M |
| 422 | AVBP | ArriVent BioPharma, Inc. | 607.47M | -8.67% | 504,998 | - |
| 423 | OLMA | Olema Pharmaceuticals, Inc. | 605.48M | -8.22% | 810,398 | - |
| 424 | ANL | Adlai Nortye Group Ltd. | 604.70M | -2.29% | 326,823 | 18.06M |
| 425 | IMMX | Immix Biopharma, Inc. | 599.39M | -9.28% | 634,923 | - |
| 426 | APMD | Apnimed, Inc. | 594.07M | -6.73% | 252,221 | 115.12M |
| 427 | TCMD | Tactile Systems Technology, Inc. | 583.67M | -4.14% | 124,949 | 356.42M |
| 428 | MYGN | Myriad Genetics, Inc. | 579.64M | 0.66% | 2,039,924 | 803.60M |
| 429 | NVCT | Nuvectis Pharma, Inc. | 571.15M | -5.09% | 223,835 | - |
| 430 | CBIO | Crescent Biopharma, Inc. | 563.69M | -4.70% | 100,649 | 11.88M |
| 431 | SOPH | SOPHiA GENETICS SA | 563.55M | -5.02% | 456,516 | 90.97M |
| 432 | NRC | NRC Health | 556.32M | -3.16% | 157,210 | 143.79M |
| 433 | ACRS | Aclaris Therapeutics, Inc. | 553.30M | -2.99% | 1,134,196 | 6.40M |
| 434 | BCAX | Bicara Therapeutics Inc. | 552.21M | -6.13% | 304,279 | - |
| 435 | VALN | Valneva SE | 551.31M | 2.31% | 3,069 | 163.30M |
| 436 | SGHT | Sight Sciences, Inc. | 544.27M | 2.07% | 464,055 | 88.40M |
| 437 | NGNE | Neurogene Inc. | 538.91M | -2.36% | 165,853 | 925.00K |
| 438 | AVR | Anteris Technologies Global Corp. | 536.21M | -10.13% | 818,913 | 2.24M |
| 439 | IAM | Iambic Therapeutics, Inc. | 526.86M | -17.05% | 522,412 | 18.25M |
| 440 | EVH | Evolent Health, Inc. | 526.29M | -3.02% | 2,056,708 | 2.34B |
| 441 | PBYI | Puma Biotechnology, Inc. | 519.30M | -5.89% | 184,677 | 231.24M |
| 442 | ENTX | Entera Bio Ltd. | 518.29M | -4.18% | 133,736 | 42.00K |
| 443 | CLYM | Climb Bio, Inc. | 518.08M | -3.32% | 566,253 | - |
| 444 | SRZN | Surrozen, Inc. | 515.32M | -6.94% | 135,797 | 11.51M |
| 445 | SLBT | SL Science Holding Limited | 514.89M | -18.66% | 122,495 | 3.27M |
| 446 | FLGT | Fulgent Genetics, Inc. | 509.86M | -5.84% | 142,459 | 323.93M |
| 447 | FTH | Faeth Therapeutics, Inc. | 505.70M | -2.10% | 138,038 | - |
| 448 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 449 | RGNX | REGENXBIO Inc. | 500.38M | -1.69% | 650,659 | 153.91M |
| 450 | DMAC | DiaMedica Therapeutics Inc. | 499.35M | -14.02% | 187,196 | - |
| 451 | DCTH | Delcath Systems, Inc. | 497.93M | -3.17% | 284,481 | 95.42M |
| 452 | CAPR | Capricor Therapeutics, Inc. | 497.09M | -4.15% | 2,651,127 | 11.13M |
| 453 | OVID | Ovid Therapeutics Inc. | 494.10M | -7.66% | 862,132 | 1.58M |
| 454 | TKNO | Alpha Teknova, Inc. | 492.39M | 8.28% | 734,236 | 45.95M |
| 455 | ANGO | AngioDynamics, Inc. | 487.41M | -5.39% | 170,794 | 325.38M |
| 456 | YDES | YD Bio Limited | 478.11M | -2.88% | 44,240 | 1.24M |
| 457 | RCEL | AVITA Medical, Inc. | 474.42M | -6.00% | 274,618 | 75.63M |
| 458 | CTMX | CytomX Therapeutics, Inc. | 472.84M | -7.66% | 1,638,289 | 18.30M |
| 459 | AQST | Aquestive Therapeutics, Inc. | 469.44M | -1.71% | 1,735,154 | 48.84M |
| 460 | INDP | Indaptus Therapeutics, Inc. | 468.42M | -7.58% | 121,942 | - |
| 461 | STTK | Shattuck Labs, Inc. | 463.68M | -10.29% | 698,995 | 1.00M |
| 462 | MNPR | Monopar Therapeutics Inc. | 460.12M | -5.85% | 74,234 | - |
| 463 | SRTA | Strata Critical Medical, Inc. | 460.00M | -1.34% | 878,536 | 280.76M |
| 464 | EOLS | Evolus, Inc. | 456.74M | -7.43% | 1,070,418 | 325.47M |
| 465 | ETRA | Electra Therapeutics, Inc. | 456.32M | -8.78% | 231,055 | - |
| 466 | MDXG | MiMedx Group, Inc. | 451.64M | -3.28% | 1,488,617 | 303.73M |
| 467 | EPRX | Eupraxia Pharmaceuticals Inc. | 440.91M | -1.48% | 560,555 | - |
| 468 | GYRE | Gyre Therapeutics, Inc. | 438.98M | -6.76% | 200,040 | 109.82M |
| 469 | ARVN | Arvinas, Inc. | 437.44M | -9.97% | 570,808 | 275.30M |
| 470 | OCS | Oculis Holding AG | 429.04M | -4.53% | 176,780 | 1.12M |
| 471 | NPCE | NeuroPace, Inc. | 426.99M | -6.75% | 52,464 | 106.99M |
| 472 | SI | Shoulder Innovations, Inc. | 424.71M | -2.90% | 78,411 | 60.06M |
| 473 | BWAY | BrainsWay Ltd. | 424.50M | -5.58% | 43,502 | 60.70M |
| 474 | SENS | Senseonics Holdings, Inc. | 420.88M | -11.75% | 499,385 | 48.55M |
| 475 | PHAT | Phathom Pharmaceuticals, Inc. | 420.19M | -6.87% | 549,251 | 274.88M |
| 476 | CERS | Cerus Corporation | 417.04M | -14.49% | 1,392,407 | 226.57M |
| 477 | MASS | 908 Devices Inc. | 412.92M | -9.76% | 289,055 | 60.84M |
| 478 | PRTA | Prothena Corporation plc | 411.72M | -4.41% | 272,919 | 54.53M |
| 479 | CARL | Carlsmed, Inc. | 410.91M | -6.46% | 80,519 | 63.30M |
| 480 | CRMD | CorMedix Inc. | 410.77M | -6.89% | 1,018,594 | 462.25M |
| 481 | RLMD | Relmada Therapeutics, Inc. | 409.61M | -7.91% | 910,147 | - |
| 482 | TLRY | Tilray Brands, Inc. | 406.26M | -6.42% | 5,599,578 | 963.10M |
| 483 | ASMB | Assembly Biosciences, Inc. | 402.73M | -0.45% | 160,772 | 74.85M |
| 484 | EDIT | Editas Medicine, Inc. | 387.02M | -7.35% | 1,278,560 | 47.01M |
| 485 | BLSM | BlossomHill Therapeutics, Inc. | 385.23M | -2.10% | 222,521 | - |
| 486 | RZLT | Rezolute, Inc. | 383.92M | -7.58% | 638,347 | - |
| 487 | TECX | Tectonic Therapeutic, Inc. | 379.36M | -4.41% | 47,832 | - |
| 488 | PRLD | Prelude Therapeutics Incorporated | 379.02M | -9.80% | 125,828 | 22.42M |
| 489 | ALT | Altimmune, Inc. | 378.34M | -8.25% | 2,417,377 | 31.00K |
| 490 | SSII | SS Innovations International, Inc. | 377.73M | -16.96% | 120,252 | 52.40M |
| 491 | KMDA | Kamada Ltd. | 376.63M | -7.68% | 177,681 | 191.85M |
| 492 | CCCC | C4 Therapeutics, Inc. | 375.23M | -2.24% | 1,655,097 | 32.28M |
| 493 | ALLO | Allogene Therapeutics, Inc. | 374.86M | -8.82% | 10,313,634 | 4.64M |
| 494 | MOBI | Mobia Medical, Inc. | 368.53M | -1.51% | 114,867 | 45.28M |
| 495 | AVTX | Avalo Therapeutics, Inc. | 359.86M | -5.09% | 462,524 | 59.00K |
| 496 | ZURA | Zura Bio Limited | 358.81M | -7.34% | 1,764,797 | - |
| 497 | OFIX | Orthofix Medical Inc. | 356.41M | -9.98% | 952,097 | 833.19M |
| 498 | MPLT | MapLight Therapeutics, Inc. | 355.13M | -4.77% | 183,578 | - |
| 499 | EMBC | Embecta Corp. | 354.97M | -3.91% | 433,843 | 1.02B |
| 500 | ASPE | Aspen Neuroscience, Inc. | 352.72M | -4.94% | 103,828 | - |